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1 | INTRODUCTION
During the current SARS-CoV-2 pandemic dementia has been identi-
fied as disproportionally common in adults aged over 65 who develop
severe COVID-19.1 Observational data from the International Severe
Acute Respiratory and Emerging Infections Consortium also confirms
a high prevalence of dementia in older adults hospitalised with
COVID-19.2 It is so far unclear whether there is any direct effect of
dementia pathologies as dementia is a disease of old age, and thus
likely to be associated with a variety of comorbidities, in particular,
frailty, which may further exacerbate the risk of severe infection. In
addition up to one third of COVID patients have demonstrated neuro-
logical sequelae3 and there may be both direct (viral infection within
the brain, vascular effects) and indirect effects (eg, host immunological
response, impact of treatment) of SARS-CoV-2 on the brain.4 It is
therefore possible that SARS-CoV-2 infection may accentuate any
pre-existing neurodegenerative disease.
Dementia with Lewy bodies (DLB) represents at least 4.2% of
community-based dementia, and 7.5% of cases in clinical dementia
populations.5 Under-diagnosis is however common, meaning the true
figure is likely to be higher.6 This form of dementia presents with sev-
eral distinct cognitive, neuropsychiatric, sleep, autonomic and motor
symptoms. These include spontaneous alterations in concentration
and attention, recurrent well-formed visual hallucinations, and rapid
eye movement (REM) sleep behaviour disorder. Further problems
relate to severe autonomic dysfunction (eg, severe constipation,
orthostatic hypotension, and urinary difficulties), and spontaneous
features of Parkinsonism, including gait impairment.7 People with DLB
are admitted to hospital more frequently, and utilize inpatient care to
a substantially higher degree, than people with Alzheimer's disease
(AD) or the general elderly population.8 They also have higher and
earlier mortality than people with other dementias.9,10
The myriad of symptoms associated with DLB results in a
complex condition with significant functional disability and a likely
vulnerability to COVID-19. Furthermore, DLB patients may be biased
against in treatment decision algorithms that consider multimorbidity,
particularly for critical care access. For example within the UK, the
current NICE guidance on critical care for COVID-19 algorithm
(https://www.nice.org.uk/guidance/NG159) uses the Clinical Frailty
Scale, whereby a higher category of frailty reduces the likelihood of
receiving critical care. On a measure of this type, it is probable that
people with DLB would score highly as a consequence of both their
physical and their cognitive problems.
As the current wave of COVID-19 recedes and jurisdictions move
to staged social distancing, people with DLB may need to remain
shielded longer than some other groups due to their susceptibility and
age profile. Even where a person with DLB avoids developing COVID-
19 and hospitalisation, adverse outcomes may result from this period
of enforced social isolation. People with DLB invariably have their
healthcare needs managed by professionals from a wide variety of
specialties, including doctors (primary care, psychiatrists, neurologists,
geriatricians), nurses, psychologists, occupational therapists, pharma-
cists, carers, social workers and physiotherapists, in addition to
benefiting from the support of charities and community groups. This
raises a particular challenge as shielding or social isolation risks at least
some healthcare and psychosocial needs remaining unmet.
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2 | PHYSICAL CHALLENGES
One feature of DLB is an increased risk of infection, notably
bronchopneumonia.11 This is particularly concerning during the
current pandemic, where it might exacerbate, or be mistaken for
COVID-19 symptoms. Secondary pneumonias may be more common
given that people with DLB often have a pharyngeal-type dysfunction,
which results in a high prevalence of silent aspiration.12 This could
contribute to diagnostic difficulty especially in conjunction with
anosmia, another symptom commonly associated with DLB,13 and
which is also indicative of COVID-19.
In common with other dementias, a person with DLB may fail to
notice or report symptoms, of, for example, fever, which may indicate
COVID-19 or another infection. Furthermore, coupled with a reduc-
tion in the availability of face-to-face healthcare provision, infections
may progress significantly before detection. Family caregivers are
important partners in detecting changes in normal behaviour, which
may indicate a developing illness. However, they may need guidance
in asking appropriate questions particularly where they are living apart
and maintaining contact by phone.
In the UK ‘Telemedicine’ is replacing many face-to face consul-
tations during the current pandemic and is being viewed as a poten-
tial longer-term alternative for primary care.14 In addition to age
related hearing/visual impairment, people with DLB may find this
form of communication particularly challenging to navigate espe-
cially when they are feeling unwell. They have significantly more
visual complaints when compared to people with AD, including mis-
judging objects, difficulty reading, and increased double vision15 and
thus could struggle to interact with the virtual medium. Language
dysfunction is more severe in DLB than other dementias and
includes impairments of speech fluency, speech freezing, reduced
pitch range and hypophonia.16,17 This may lead to problems in both
responding to on-screen questions and being understood. Such chal-
lenges need consideration when transforming services to ensure
equality of access.
People with DLB are at increased risk of developing delirium if
they develop an infection compared with AD.18 As infection pro-
gresses in severity, treatment becomes more difficult and the risk of
delirium and hospitalisation increases. The maintenance of good gen-
eral hygiene is therefore important to reinforce, for example, where
there are continence difficulties, as urinary tract infections can esca-
late quickly. It is also vital that family caregivers understand the
importance of the early assessment of suspected infections by a
health care professional. This could include reassurance that per-
ceived pressures on healthcare staff and concerns about over-
burdening services do not warrant any delay in seeking help. It is
important that caregivers inform health care professionals of the DLB
diagnosis in any communication. This will highlight to them the need
for caution when prescribing anti-psychotic medication due to the risk
of a severe sensitivity syndrome.19 Families can assist healthcare pro-
fessionals to differentiate between fluctuations commonly experi-
enced by their family member and unfamiliar behaviour that may
indicate delirium.
Avoiding unnecessary hospital admissions is important, as the
change of environment and routine are likely to increase confusion in
people with DLB. They may feel particularly isolated if visiting is
restricted and they are unable to manage phone contact. It may be
advisable for family caregivers to consider in advance whether the per-
son with DLB is sufficiently cognitively aware to express their wishes or
preferences regarding any future hospital admission or treatment.
People with DLB may have difficulty in understanding and follow-
ing instructions regarding the importance of good hand hygiene in
reducing the risk of COVID-19 transmission. Clear, straightforward
explanations are key, with frequent repetition as needed. Signs or pic-
tures can be attached above sinks to act as prompts, and caregivers
can model good handwashing practice, and give positive reinforce-
ment of successful performance. If the care-recipient is reluctant, sit-
ting with a bowl of water rather than standing at the sink or
incorporating a hand massage may be welcomed. With appropriate
signposting, less cognitively impaired people with DLB may be able to
access videos demonstrating handwashing techniques.
Other physical symptoms of concern include orthostatic hypoten-
sion. This is more common in DLB than other dementias with a
greater reduction in systolic blood pressure and a more prolonged
period of orthostasis.20 This may increase the risk of falls, which is
also higher for people with DLB than for other dementias.21 This pos-
sibility is exacerbated by poor hydration, a potential concern if people
are missing the usual prompts from family caregivers. Good hydration
can be maintained through reminders by phone, sharing drinks virtu-
ally during video calls or alarms set at regular intervals. If there is a risk
of falls going undetected, families may need guidance to assess the
relative risks of visiting rather than remaining physically distant.
Healthcare professionals should be willing to support families in
assessing these risks and helping them reach decisions about the most
appropriate level of contact. This should take into account both
national guidance and the needs of the individual with DLB.
Many people with DLB take short daily walks or participate in
low-level exercise classes offered by gyms or day centres. Regular
exercise can interrupt the trajectory of frailty, limitations in mobility,
stiffness and sarcopenia, often evident in DLB. Benefits include
improvements in gait speed and in the daily activities subsection of
Key points
• The physical, cognitive and neuropsychiatric challenges
associated with dementia with Lewy bodies make people
particularly vulnerable to COVID-19.
• Adverse effects may also occur from social isolation, the
under-treatment of existing DLB related symptoms/prob-
lems and the negative impact on caregivers.
• A vigilant multi-disciplinary approach is needed to meet
the health and psychosocial needs of people with DLB
and support family caregivers.
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the UPDRS.22 While the exercise capacity of people with DLB is rela-
tively low in comparison with other cohorts with dementia, any reduc-
tion may heighten the falls risk. Maintaining safe home-based
activities, for example, by following appropriate on-line fitness
programmes, in many cases with assistance, may reduce the impact of
the lost exercise opportunities and minimise skeletal or muscular pain
from reduced mobility.
2.1 | Cognitive and neuropsychiatric challenges
A lack of meaningful activity adversely affects quality of life in people
with dementia,23 and people with DLB benefit from cognitively stimu-
lating activities.24 They may find the sudden loss of these and the
changes to their daily routine necessitated in response to COVID-19
difficult to comprehend. They may also struggle to understand the
need for social isolation, and misinterpret the reason for the lack of
visits from family and friends. People with DLB may react with anxi-
ety, anger, stress, or withdrawal in response to worry they perceive in
others, or news events about which they have limited understanding.
Caregivers can assist by sharing simple non-threatening messages
about COVID-19, emphasising the temporary nature of the situation,
and reassuring the person with DLB of their continued importance to
them despite their physical absence. Frequent, brief communication is
probably of more value than extended contact where concentration
may be difficult to sustain, especially over unfamiliar media platforms.
Non-pharmacological treatment modalities are recommended to
manage behavioural disturbance in people with dementia.25,26 This is
particularly salient given that delivering face-to-face or group non-
pharmacological interventions to reduce agitation, for example, music
therapy or sensory stimulation,27 may be impossible due to the difficul-
ties in maintaining social distancing. Any resurgence or development of
behavioural difficulties may therefore require pharmacological interven-
tions, and caregivers should be alert to the need to discuss concerns
and treatment options with health care professionals.
Depression or low mood are common features of DLB28 with
depression more frequent than in AD.29 Depressive symptoms also differ
between DLB and AD with apathy and pervasive anhedonia significantly
higher in people with DLB.30 Apathy often responds to stimulation from
social activities and in the absence of these, is important to find alterna-
tives, for example assisting with household tasks, baking or straightfor-
ward games. Family caregivers can be encouraged to offer managed
choices to reduce any perceived loss of control over how the day is
spent. If the person with DLB lives alone and seems disinclined to initiate
available activities such as jigsaws, crafts or gardening, caregivers can be
encouraged to prompt, enthuse and encourage via any accessible commu-
nication routes. Resources to enhance activities can be ordered online
and depending on the level of impairment, turn-taking activities may be
possible via video calls to maintain engagement. Family caregivers should
be advised to contact a health care professional if they detect a
deterioration in mood as changes to medication may be warranted.
Reduced social stimulation, a lack of daytime routine, and less
physical activity may exacerbate excessive daytime somnolence, a
common feature of DLB,31 and result in poorer night-time sleep. Where
COVID-19 guidelines permit, outside exercise can help to regulate this.
If the person with DLB is safe to go out alone or accompanied, and
compliant with social distancing, a daily walk offers the benefits of both
physical exercise and exposure to daylight for melatonin synthesis. Psy-
chological benefits include adding variety to the day, the stimulation of
different surroundings and the opportunity to engage at an appropriate
distance with passers-by. Where the weather and circumstances allow,
sitting in the garden or at an open front door while maintaining social
distancing may also be worthwhile.
Recurrent complex visual hallucinations are a common feature of
DLB. They cause significant distress in around 50% of people who
experience them, with fear and anger being the most common
responses.32 They tend to occur in the same location, which is most
often within the house, frequently the living room or looking out of
the window.33 Worsening of visual hallucinations, often coupled with
increasing confusion might herald an undiagnosed delirium or infec-
tion. However while this possibility should be excluded, hallucinations
may also increase in frequency and intensity with more time spent at
home and in the rooms where they are typically experienced, particu-
larly where combined with social isolation and reduced sensory input
and stimulation from others. People with DLB and caregivers should
be alerted to this, and where the hallucinations are causing distress,
be given the opportunity to discuss the range of treatment options.
Guidelines include both pharmacological and non-pharmacological
strategies30 and caregivers can be advised to try distraction, reassur-
ance and bright lighting to try to minimise the occurrence. Rear-
ranging the furniture to alter the location of any items causing
misperceptions may help, as can trying to ensure that any corrective
lenses, are clean, easily accessible and worn.
Delusions, another common feature of DLB may also increase as
a result of anxiety or agitation, perhaps in conjunction with overheard
or poorly understood conversations, or news reports that include
unfamiliar scenes, such as people wearing personal protective equip-
ment (PPE). Family caregivers can be encouraged to balance their own
need to keep informed with protecting the care-recipient to avoid
triggering or reinforcing this behaviour.
Including collateral information from family caregivers in the clini-
cal assessment of neuropsychiatric symptoms is essential to diagnosis
and management because people with DLB frequently lack insight
regarding the extent of their impairment.34 It is important to find ways
to facilitate this into telemedicine consultations even when caregivers
live physically distant from the care-recipient. Many people with DLB
incorporate what is on the screen into their delusions and the absence
of the usual cues of surroundings, equipment or uniforms to make
them aware they are talking to a health care professional may cause
confusion and present an added challenge.
2.2 | Challenges for family caregivers
Supporting someone with DLB poses a substantial burden on family
caregivers. Compared with AD, caregiver burden in family caregivers
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of people with DLB is rated 30% higher on the Relative Stress Scale35
and a major depressive disorder in the caregiver is significantly more
likely.36 The COVID-19 pandemic is likely to create multiple further
difficulties.
Physical outcomes may include caregiver fatigue from the
increased hours spent supporting the person with DLB with the
everyday activities of living, particularly in spousal caregivers who
may have age related physical limitations. Additional personal care
needs may arise where formal caregivers are unable to visit and rou-
tine appointments such as podiatry are unavailable. Many families rely
on respite from daycentres or short-term care home admission to
reduce caregiving hours and care demands to a manageable level. The
closure of these removes the opportunity for caregivers to ‘recharge’
and requires them to be constantly available. This may be particularly
difficult where there is no foreseeable end in sight.
Mental health challenges for caregivers include managing their
own anxiety and coping with uncertainty, including over the duration
of isolation, whilst containing anxiety in their care-recipient. Finding
ways to accommodate changes to dietary preferences in the face of
shortages in essential food items may be stressful. Difficulty obtaining
regular prescriptions and appointments such as physiotherapy to
maintain mobility may also be concerning for caregivers who are likely
to be aware of the detrimental effects of being without these. Feel-
ings of anticipatory grief related to a DLB diagnosis contribute to
caregiver burden37 and may be heightened by anxiety about their
family member contracting COVID-19. Caregivers with co-morbidities
which put them in a high-risk group, may worry about becoming ill
themselves, and miss the companionship and emotional support of fri-
ends and family while socially isolated. They may experience poor
sleep as a result of their own anxieties and disturbed sleep in the
care-recipient. Finally caregivers may be disturbed by insensitive
media coverage regarding access to critical care, unsure whether or
how to undertake advance care planning conversations and nervous
about taking responsibility for best interest decisions.
Where the person with DLB is in a care home, caregivers may be
distressed by the lack of visiting opportunities and the effect of this
on the care-recipient. They may fear the spread of COVID-19 from
other residents and experience a lack of purpose without their normal
visiting routine. Both caregiver and care-recipient may find the lack of
physical touch through being unable to hug or hand hold difficult to
manage. Sending in personal items such as photographs, familiar scent
worn by the caregiver or playlists may provide some comfort.
It is essential that caregivers of people with DLB feel well
supported to enable them to maintain their caregiving role during the
COVID-19 crisis, and health and social care professionals can be
sources of both practical and emotional support. Guidelines such as
the UK Royal College of Psychiatrists Standards for Memory Ser-
vices38 recommend that caregivers receive a person-centred service
that takes into account their unique and changing personal, psychoso-
cial and physical needs. This includes offering individual time with
staff to discuss their own needs. Wellbeing checks instigated by tele-
phone or video call through clinical services such as memory clinics
should therefore include caregivers' needs in their assessments.
Suggestions to caregivers may include trying to concentrate on those
things they can control, that is, making a contingency plan for if they
get ill, keeping up good nutrition, and maintaining a daily routine
rather than focussing on situations that they cannot control. This may
include limiting the time spent watching news updates. They may be
encouraged to consider how they have coped with previous challeng-
ing situations and whether they can adopt similar techniques again.
Practical solutions to pressing problems such as arranging volunteer
shoppers and medication deliveries may be as important as offering
psychological support.
Detrimental effects for caregivers may also be reduced through
maintaining contact with their informal social networks, bearing in
mind that where platforms such as video calls are unfamiliar, addi-
tional support may be needed. Carers' organisations and faith groups
may be beneficial as may opportunities to ‘buddy’ other caregivers
and so offer as well as receive support. Accessing DLB specific advice
and information from charities such as the Lewy Body Dementia
Association (https://lbda.org) and the Lewy Body Society (https://
lewybody.org) can also be encouraged.
2.3 | Challenges for primary care/generalist
services
During the urgent restructuring in response to COVID-19, specialist
services in hospital-based clinics were suspended, and many people
with DLB only had access to primary care. Although some services
were subsequently reinstated as telephone or video consultations, this
highlights an important concern about how primary care teams can
access specialist advice and feel equipped to provide proxy specialist
care when the need arises. Establishing links between health care pro-
fessionals in these areas is vital to enable case discussions and
requests for urgent reviews to take place, and to facilitate sharing of
current practice. This could include distributing details of updated
working arrangements and contact details in situations where normal
services are undeliverable.
There are other routes by which generalist and primary care ser-
vices can access information on the best management and care of
people with DLB. Many countries employ dementia nurses and they
are increasingly taking on proactive roles in the advising on the man-
agement of dementia in community settings. In the UK, the first Admi-
ral Nurse specifically for Lewy body dementias has recently been
appointed39 with a remit that includes supporting health care profes-
sionals through telephone advice and the development of training
material. A further source of DLB specific information for primary care
and generalist services is available via the UK National Institute for
Health Research (NIHR) funded Diamond Lewy website https://
research.ncl.ac.uk/diamondlewy/. The Diamond Lewy study aimed to
improve the diagnosis and management of Lewy body dementia
including DLB. Freely downloadable resources include assessments
for recognising and diagnosing DLB and summary sheets and detailed
recommendations for managing key symptoms. These align with the
most recent Consensus Report of the DLB consortium on the
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diagnosis and management of DLB.40,41 They are ideally placed to
guide health care professionals having undergone piloting and feasibil-
ity testing, and been evaluated as acceptable by clinicians working in
general dementia services.42
3 | CONCLUSION
While the effects of COVID-19 are widespread, it is important to rec-
ognise the challenges presented by the significant vulnerabilities asso-
ciated with DLB. There is a pressing need for research to study the
impact of COVID-19 on this population including ensuring that people
with DLB are not excluded from studies because of their age,
shielding protocols or their dementia diagnosis. Utilising the person-
centred, problem-solving approach highlighted here including recogni-
tion of the value of a multidisciplinary response can mitigate some of
the adverse effects of COVID-19. This should enable people with
DLB and family caregivers to have their health and psychosocial care
needs met in the short term, and develop resilience to withstand
future COVID-19 related challenges.
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